Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 99tc Radioisotope
2. Tc-99 Radioisotope
3. Technetium-99
1. Technetium-99
2. Technetium-99m
3. Technetium-99mtc
4. Technetium, Isotope Of Mass 99
5. 99tc
6. Technetium 99m
7. 14133-76-7
8. Tc 99
9. Technetium Tc 99m
10. Technetium (99mtc)
11. Technetium, Tc-99m
12. Technetium (tc 99m)
13. 6ew75241vu
14. Cea-scan
15. Arcitumomab Technetium-99m
16. Technetium-99m Arcitumomab
17. Unii-029jf1scu8
18. Technegas
19. Technetium Tc 99m Arcitumomab
20. Unii-6ew75241vu
21. Cea Scan
22. Technetium,tc-99m
23. Tc-99m Arcitumomab
24. Arcitumomab 99mtc-labeled Form [mi]
25. Technetium-99m Arcitumomab [who-dd]
26. Technetium 99m Metal
27. 029jf1scu8
28. Arcitumomab 99mtc-labeled Form
29. Technetium (99mtc) Arcitumomab
30. (99)tc
31. Chebi:33371
32. Dtxsid00874006
33. Technetium Tc 99m [vandf]
34. Technetium,tc-99m [vandf]
35. Arcitumomab, Technetium-99m Labeled
36. (99)43tc
37. Technetium Tc 99m [who-dd]
38. Technetium (99mtc) Technegas
39. Db14227
40. Technetium (tc 99m) [vandf]
41. 154361-49-6
| Molecular Weight | 98.906250 g/mol |
|---|---|
| Molecular Formula | Tc |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 0 |
| Exact Mass | 98.906250 g/mol |
| Monoisotopic Mass | 98.906250 g/mol |
| Topological Polar Surface Area | 0 Ų |
| Heavy Atom Count | 1 |
| Formal Charge | 0 |
| Complexity | 0 |
| Isotope Atom Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
CEA-Scan is indicated only in patients with histologically-demonstrated carcinoma of the colon or rectum for imaging of recurrence and/or metastases. CEA-Scan is employed for diagnostic use only, in the above mentioned patients, as an adjunct to standard non-invasive imaging techniques, such as ultrasonography or CT scan, in the following situations:
- Patients with evidence of recurrence and/or metastatic carcinoma of the colon or rectum, who are undergoing an evaluation for extent of disease, such as prior to surgical resection and/or other therapy, or
- Patients with suspected recurrence and/or metastatic carcinoma of the colon or rectum in association with rising levels of carcinoembryonic antigen (CEA).
V09IA01
V - Various
V09 - Diagnostic radiopharmaceuticals
V09E - Respiratory system
V09EA - Technetium (99mtc), inhalants
V09EA02 - Technetium (99mTc) technegas
V - Various
V09 - Diagnostic radiopharmaceuticals
V09I - Tumour detection
V09IA - Technetium (99mtc) compounds
V09IA06 - Technetium (99mTc) arcitumomab
DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - N/A
USFDA APPLICATION NUMBER - 19981
DOSAGE - INJECTABLE;INJECTION - N/A
USFDA APPLICATION NUMBER - 202207
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
